Additionally, to investigate the correlations between SERPINB2 and CSC populations in various cancer patients, we analyzed the co-expression of SERPINB2 in CD44-, CD133- or ALDH-positive tissue samples from breast, colorectal and liver cancer patients, respectively. This evidence concerns the gene CD44 and liver cancer.